Flow cytometric analysis of Human PBMC were stained with stimulated 3 days with 10 μg/ml PHA (Right panel) or unstimulated (Left panel) was stained with Brilliant Violet 421™ Mouse Anti-Human CD3 and PE-Cy7 Armenian hamster Anti-Human CD278 Antibody at 1.25 μl/test. Flow cytometry and data analysis were performed using BD FACSymphony™ A1 and FlowJo™ software.
Product Details
Product Details
Product Specification
Host | Armenian hamster |
Antigen | CD278 |
Synonyms | Inducible T-cell costimulator; Activation-inducible lymphocyte immunomediatory molecule; AILIM; ICOS |
Location | Cell membrane |
Accession | Q9Y6W8 |
Clone Number | S-R578 |
Antibody Type | Recombinant mAb |
Isotype | IgG |
Application | FCM |
Reactivity | Hu, Ms, Rt |
Purification | Protein G |
Concentration | 0.2 mg/ml |
Conjugation | PE-Cy7 |
Physical Appearance | Liquid |
Storage Buffer | PBS, 1% BSA, 0.3% Proclin 300 |
Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied. |
Dilution
application | dilution | species |
FCM | 1.25μl per million cells in 100μl volume | Hu |
Background
CD278, also known as ICOS (Inducible T-cell Costimulator), is a type I transmembrane glycoprotein that belongs to the CD28 family of costimulatory immunoreceptors. It is expressed on the surface of activated T cells, including cytotoxic T cells, regulatory T cells (Tregs), and other types of T cells. Its ligand, ICOSL (B7-H2 or CD275), is found on antigen-presenting cells (APCs) such as dendritic cells and macrophages, as well as on B cells. ICOS functions as a homodimer and plays a crucial role in cell-cell signaling, immune responses, and the regulation of cell proliferation. The interaction between ICOS and ICOSL enhances T-cell activation, proliferation, and differentiation, and is essential for the development of follicular helper T cells (Tfh) and efficient B-cell antibody responses. ICOS has also been implicated in various disorders, including immunodeficiency and autoimmune diseases. In cancer immunotherapy, ICOS expression has been identified as a potential predictive biomarker for responses to checkpoint inhibitor treatments.
Picture
Picture
FC
